Article Text

Download PDFPDF

Oncovascular surgery: is it time for a step forward in gynecologic oncology surgery?
  1. Matias Jurado and
  2. Luis Chiva
  1. Obstetrics and Gynecology, Clinica Universidad de Navarra, Pamplona, Spain
  1. Correspondence to Dr Matias Jurado, Universidad de Navarra, Pamplona 31009, Spain; mjurado{at}unav.es

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Oncovascular surgery is a new term used to define tumor resection with simultaneous reconstruction of the great vessels when the tumor infiltrates or firmly adheres to them.1 Its paradigm is that the tumor mass that invades the vascular system should not necessarily be considered an obstacle to radical resection, which often involves en-bloc resection of the tumor with infiltrated vessels.1 This approach involves pre-operative planning within a multidisciplinary team.1 The benefit of oncovascular surgery has been widely described in patients with hepato-biliary-pancreatic cancers, with an increase in complete resections and without increasing the morbidity and mortality rate.1 Similar results have been obtained in retroperitoneal soft tissue sarcoma1 and in other areas of gynecologic oncology such as the lateral compartment of the pelvis,2 retroperitoneum,3 and hepato-biliary-pancreatic region.4 But who should lead oncovascular surgery in a gynecologic oncology procedure? This topic may be complex and will vary from institution to institution, likely depending on well-organized collaborations between each sub-specialty. Woo et al5 reviewed the role of the vascular surgeon in various settings in a tertiary hospital and found that 490 (87%) requests were for intra-operative care. Among the most common reasons were lymph node dissection (42.4%), vascular invasion (26.1%), vascular exposure (15.5%), and bleeding (11.8%), with 109 (22.2%) of these as emergency calls. Lymphadenectomy was the most common reason (52.5%) for consultation in planned surgery, while bleeding (40.4%) was the most common reason for unplanned surgery, which led to a higher rate of morbidity and reaffirms the need to form an oncovascular surgery team.1

Surgical gynecologic oncology has grown over the past four decades and advanced ovarian cancer is its paradigm. Training is the cornerstone for the development of oncovascular surgery, and gaining experience as well as surgical skills in complex procedures requires a continuous process that may be accomplished through lectures, dry lab, wet lab, and dissection of cadavers.1

In conclusion, the concept of ‘oncovascular surgery’ is considered a fundamental part of the curative treatment of advanced cancers with possible vascular involvement. Well-organized collaboration between each sub-specialty with a multidisciplinary approach and adequate pre-operative planning are pivotal. The lack of studies on the frequency and relevance of vascular surgery in gynecologic oncology, as well as the scarcity of information on the vascular approach in this area, should encourage us as gynecologic oncologists to take a step forward on this endeavor.

Ethics statements

Patient consent for publication

References

Footnotes

  • Contributors LC: Conceptualization, supervision, review of draft. MJ: Conceptualization, review.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.